Janine Scholefield

Editor-in-Chief

Springer Nature

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Janine Scholefield is the Editor-in-Chief at Springer Nature Limited, United Kingdom. Her research areas include gene editing technologies, particularly CRISPR and prime editing, as well as pharmaceutical implications of genetic variations in diverse populations. She has contributed significantly to discussions on the accessibility of gene therapies in resource-limited settings and the development of human induced pluripotent stem cell lines in South Africa.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (3)

Jennifer Adair

Research Associate Professor

University of Washington

UNITED STATES

View details

Ewa Ellis

Karolinska Institutet

SWEDEN

View details

Kenneth Cornetta

Professor

Indiana State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Janine Scholefield

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Prime editing: therapeutic advances and mechanistic insights

The translational gap for gene therapies in low- and middle-income countries

CRISPR-Cas9 mediated knockout of NDUFS4 in human iPSCs: A model for mitochondrial complex I deficiency.

An African perspective on genetically diverse human induced pluripotent stem cell lines

Making gene editing accessible in resource limited environments: recommendations to guide a first-time user.

The generation of human induced pluripotent stem cell lines from individuals of Black African ancestry in South Africa.

Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis.

Impact of donor <i>CYP3A5</i> genotype on pharmacokinetics of tacrolimus in South African paediatric liver transplant patients.

The Case for Pre-Emptive Pharmacogenetic Screening in South Africa.

The African Liver Tissue Biorepository Consortium: Capacitating Population-Appropriate Drug Metabolism, Pharmacokinetics, and Pharmacogenetics Research in Drug Discovery and Development.

Collaborators (3)

Jennifer Adair

Ewa Ellis

Kenneth Cornetta

Make your next move.